AXL and cancer: Importantly, a study evaluating transcriptome analysis of 941 cancer cell lines found that high AXL mRNA levels indicate resistance to necroptosis while low RIPK3 mRNA levels predict resistance to necroptosis (Najafov et al., 2018).